CHRS : Insider Transactions for Coherus Biosciences, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Coherus Biosciences, Inc. (CHRS)

$2.27

0.10 (4.61%) as of 4:30 Fri 5/3

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

82,625,000

Market Cap:

187.56(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$1.59 - $8.14

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	223,100	223,100	223,100
Total Sell Value	$0	$449,770	$449,770	$449,770
Total People Sold	0	1	1	1
Total Sell Transactions	0	1	1	1
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 312

Page 7 of 13

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Anicetti Vincent R

Chief Operating Officer

• – –

2019-08-14

4

OE

$2.50

$6,251

D/D

2,500

21,810

-

Anicetti Vincent R

Chief Operating Officer

• – –

2019-07-15

4

AS

$19.20

$48,000

D/D

(2,500)

19,310

-

Anicetti Vincent R

Chief Operating Officer

• – –

2019-07-15

4

OE

$2.50

$6,251

D/D

2,500

21,810

-

Director

– • –

2019-07-02

4

AS

$22.61

$3,617,600

I/I

(160,000)

1,933,221

-

Director

– • –

2019-06-28

4

AS

$22.05

$4,410,000

I/I

(200,000)

2,093,221

-

Director

– • –

2019-06-20

4

AS

$21.37

$6,777,068

I/I

(317,130)

2,293,221

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-06-19

4

AS

$20.00

$77,587

D/D

(3,826)

11,513

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-06-19

4

OE

$10.05

$31,748

D/D

3,159

14,672

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-06-18

4

AS

$19.31

$57,926

D/D

(3,000)

12,180

-

Director

– • –

2019-05-31

4

A

$0.00

$0

I/I

98,152

318,066

-

Director

– • –

2019-05-31

4

D

$0.00

$0

I/I

(178,528)

0

-

Lanfear Dennis M

President & CEO

• • –

2019-05-30

4

S

$19.49

$631,282

I/I

(32,398)

1,284,184

-

Director

– • –

2019-05-22

4

AS

$20.69

$5,335,330

I/I

(257,870)

2,610,351

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-03-20

4

S

$14.92

$44,762

D/D

(3,000)

13,185

-

Lanfear Dennis M

President and CEO

• • –

2019-01-11

4

D

$12.37

$221,015

D/D

(17,867)

125,017

-

Lanfear Dennis M

President and CEO

• • –

2019-01-11

4

A

$0.00

$0

D/D

50,265

142,884

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-01-11

4

D

$12.37

$77,894

D/D

(6,297)

16,185

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2019-01-11

4

A

$0.00

$0

D/D

16,685

22,482

-

Vexler Vladimir

Chief Scientific Officer

• – –

2019-01-11

4

D

$12.37

$73,181

D/D

(5,916)

17,474

-

Vexler Vladimir

Chief Scientific Officer

• – –

2019-01-11

4

A

$0.00

$0

D/D

15,562

23,390

-

Anicetti Vincent R

Chief Operating Officer

• – –

2019-01-11

4

D

$12.37

$79,217

D/D

(6,404)

17,295

-

Anicetti Vincent R

Chief Operating Officer

• – –

2019-01-11

4

A

$0.00

$0

D/D

16,997

23,699

-

Viret Jean-Frederic

Chief Financial Officer

• – –

2018-09-21

4

OE

$13.50

$9,990

D/D

740

4,519

-

Finck Barbara K

Chief Medical Officer

• – –

2018-09-10

4

AS

$18.58

$32,699

D/D

(1,760)

37,043

-

Finck Barbara K

Chief Medical Officer

• – –

2018-09-10

4

OE

$1.42

$2,499

D/D

1,760

38,803

-

312 Records found	1 2 3 4 5 6 7 8 9 Next	Page 7 of 13

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.